Skip to content

MARRONE BIO INNOVATIONS INC.: filings

Every MARRONE BIO INNOVATIONS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 36 filings, each linked to its SEC index.

Filing record ends 2022-05-13

The latest filing in this captured record is a 10-Q filed 2022-05-13. No later filing is in the SEC companyfacts record captured on 2026-09-22. MARRONE BIO INNOVATIONS INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-05-13fiscal Q1 202248960001493152-22-013374
10-K/A2022-05-09fiscal FY 2021541060001493152-22-012535
10-K2022-03-30fiscal FY 2021521020001493152-22-008186
10-Q2021-11-10fiscal Q3 2021461320001493152-21-027856
10-Q2021-08-16fiscal Q2 2021461300001493152-21-020156
10-Q2021-05-13fiscal Q1 202146920001493152-21-011346
10-K2021-03-23fiscal FY 202050960001493152-21-006648
10-Q2020-11-09fiscal Q3 2020431210001493152-20-020840
10-Q2020-08-10fiscal Q2 2020421130001493152-20-015114
10-Q2020-05-11fiscal Q1 202045890001493152-20-008272
10-K2020-03-16fiscal FY 201949910001493152-20-004083
10-Q2019-11-19fiscal Q3 2019441190001493152-19-017871
10-Q2019-08-09fiscal Q2 2019411090001493152-19-011950
10-Q2019-05-10fiscal Q1 201941810001493152-19-006823
10-K2019-03-29fiscal FY 201843910001493152-19-004161
10-Q2018-11-14fiscal Q3 2018401070001493152-18-016194
10-Q2018-08-14fiscal Q2 2018401070001493152-18-011825
10-Q2018-05-15fiscal Q1 201837740001493152-18-007178
10-K2018-04-05fiscal FY 2017391250001493152-18-004788
10-Q2017-11-14fiscal Q3 2017371030001493152-17-013258
10-Q2017-08-14fiscal Q2 2017371050001564590-17-017685
10-Q2017-05-15fiscal Q1 201736740001564590-17-010843
10-K2017-04-03fiscal FY 2016391260001564590-17-005870
10-Q2016-11-14fiscal Q3 2016361040001564590-16-029246
10-Q2016-08-15fiscal Q2 2016371060001193125-16-681925
10-Q2016-05-16fiscal Q1 201637760001193125-16-591976
10-K2016-03-30fiscal FY 2015461470001193125-16-523740
10-Q2015-11-16fiscal Q3 2015381080001193125-15-378465
10-Q2015-11-10fiscal Q2 2015381080001193125-15-372838
10-Q2015-11-10fiscal Q1 201537760001193125-15-372827
10-K2015-11-10fiscal FY 2014464660001193125-15-372823
10-Q2014-08-13fiscal Q2 2014411200001193125-14-308547
10-Q2014-05-15fiscal Q1 201437760001193125-14-201008
10-K2014-03-25fiscal FY 2013431710001193125-14-114512
10-Q2013-11-08fiscal Q3 2013421210001193125-13-435430
10-Q2013-09-13fiscal Q2 2013391080001193125-13-366573

Inspect the source

Entity
MARRONE BIO INNOVATIONS INC. / CIK 0001441693
Captured
SEC response SHA-256
a3787009c5cf9f0620a14ee2be8261876f11bbb6e3e32c9de2e3e341c6f35189

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001441693.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))